118 related articles for article (PubMed ID: 9150287)
41. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
42. Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
Binder W; Machelska H; Mousa S; Schmitt T; Rivière PJ; Junien JL; Stein C; Schäfer M
Anesthesiology; 2001 Jun; 94(6):1034-44. PubMed ID: 11465595
[TBL] [Abstract][Full Text] [Related]
43. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
Long JB; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
[TBL] [Abstract][Full Text] [Related]
44. Stabilized dynorphin derivatives for modulating antinociceptive activity in morphine tolerant rats: effect of different routes of administration.
Brugos B; Arya V; Hochhaus G
AAPS J; 2004 Dec; 6(4):e36. PubMed ID: 15760101
[TBL] [Abstract][Full Text] [Related]
45. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration.
Lackó E; Riba P; Giricz Z; Váradi A; Cornic L; Balogh M; Király K; Csekő K; Mousa SA; Hosztafi S; Schäfer M; Zádori ZS; Helyes Z; Ferdinandy P; Fürst S; Al-Khrasani M
J Pharmacol Exp Ther; 2016 Oct; 359(1):171-81. PubMed ID: 27435180
[TBL] [Abstract][Full Text] [Related]
46. The effect of a paracetamol and morphine combination on dynorphin A levels in the rat brain.
Sandrini M; Romualdi P; Vitale G; Morelli G; Capobianco A; Pini LA; Candeletti S
Biochem Pharmacol; 2001 Jun; 61(11):1409-16. PubMed ID: 11331077
[TBL] [Abstract][Full Text] [Related]
47. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats.
Ren K; Williams GM; Hylden JL; Ruda MA; Dubner R
Eur J Pharmacol; 1992 Aug; 219(2):235-43. PubMed ID: 1358641
[TBL] [Abstract][Full Text] [Related]
48. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
49. Peripheral opioid modulation of pain and inflammation in the formalin test.
Hong Y; Abbott FV
Eur J Pharmacol; 1995 Apr; 277(1):21-8. PubMed ID: 7635169
[TBL] [Abstract][Full Text] [Related]
50. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
Rogers H; Birch PJ; Harrison SM; Palmer E; Manchee GR; Judd DB; Naylor A; Scopes DI; Hayes AG
Br J Pharmacol; 1992 Aug; 106(4):783-9. PubMed ID: 1327387
[TBL] [Abstract][Full Text] [Related]
51. Peripheral antinociceptive effects of mu- and delta-opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic inflammatory pain.
Leánez S; Hervera A; Pol O
Eur J Pharmacol; 2009 Jan; 602(1):41-9. PubMed ID: 19041302
[TBL] [Abstract][Full Text] [Related]
52. Spinal dynorphin A (1-17): possible mediator of antianalgesic action.
Fujimoto JM; Arts KS; Rady JJ; Tseng LF
Neuropharmacology; 1990 Jul; 29(7):609-17. PubMed ID: 1974711
[TBL] [Abstract][Full Text] [Related]
53. Modulation of tight junction proteins in the perineurium to facilitate peripheral opioid analgesia.
Rittner HL; Amasheh S; Moshourab R; Hackel D; Yamdeu RS; Mousa SA; Fromm M; Stein C; Brack A
Anesthesiology; 2012 Jun; 116(6):1323-34. PubMed ID: 22534246
[TBL] [Abstract][Full Text] [Related]
54. Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats.
Cook CD; Nickerson MD
J Pharmacol Exp Ther; 2005 Apr; 313(1):449-59. PubMed ID: 15608071
[TBL] [Abstract][Full Text] [Related]
55. Self-administration of dynorphin-[1-13] and D-ala2-dynorphin-[1-11] (kappa opioid agonists) in morphine (mu opioid agonist)-dependent rats.
Khazan N; Young GA; Calligaro D
Life Sci; 1983; 33 Suppl 1():559-62. PubMed ID: 6319910
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain.
Sykes KT; White SR; Hurley RW; Mizoguchi H; Tseng LF; Hammond DL
J Pharmacol Exp Ther; 2007 Aug; 322(2):813-21. PubMed ID: 17494863
[TBL] [Abstract][Full Text] [Related]
57. The increase in morphine antinociceptive potency produced by carrageenan-induced hindpaw inflammation is blocked by naltrindole, a selective delta-opioid antagonist.
Ossipov MH; Kovelowski CJ; Porreca F
Neurosci Lett; 1995 Jan; 184(3):173-6. PubMed ID: 7715840
[TBL] [Abstract][Full Text] [Related]
58. Lumbar but not cervical intrathecal DAMGO suppresses extrasegmental nociception in awake rats.
Kusmirek J; Owens CA; Mason P
Brain Res; 1997 Sep; 767(2):375-9. PubMed ID: 9367272
[TBL] [Abstract][Full Text] [Related]
59. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
60. Treatment of chronic allodynia in spinally injured rats: effects of intrathecal selective opioid receptor agonists.
Hao JX; Yu W; Wiesenfeld-Hallin Z; Xu XJ
Pain; 1998 Apr; 75(2-3):209-17. PubMed ID: 9583756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
